Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice
Pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptors (PAC1, VPAC) are present in sensory neurons and vascular smooth muscle. PACAP infusion was found to trigger migraine-like headache in humans and we showed its central pro-nociceptive function in several mouse pain models. N...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2012-01-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996111003421 |
id |
doaj-af168d60755641929d761c3edfb1b7ff |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Adrienn Markovics Viktoria Kormos Balazs Gaszner Arvin Lashgarara Eva Szoke Katalin Sandor Krisztina Szabadfi Bernadett Tuka Janos Tajti Janos Szolcsanyi Erika Pinter Hitoshi Hashimoto Jozsef Kun Dora Reglodi Zsuzsanna Helyes |
spellingShingle |
Adrienn Markovics Viktoria Kormos Balazs Gaszner Arvin Lashgarara Eva Szoke Katalin Sandor Krisztina Szabadfi Bernadett Tuka Janos Tajti Janos Szolcsanyi Erika Pinter Hitoshi Hashimoto Jozsef Kun Dora Reglodi Zsuzsanna Helyes Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice Neurobiology of Disease Light-aversive behavior Light–dark box Laser Doppler blood perfusion scanning Meningeal microcirculation c-Fos immunohistochemistry PAC1 receptor immunohistochemistry |
author_facet |
Adrienn Markovics Viktoria Kormos Balazs Gaszner Arvin Lashgarara Eva Szoke Katalin Sandor Krisztina Szabadfi Bernadett Tuka Janos Tajti Janos Szolcsanyi Erika Pinter Hitoshi Hashimoto Jozsef Kun Dora Reglodi Zsuzsanna Helyes |
author_sort |
Adrienn Markovics |
title |
Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice |
title_short |
Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice |
title_full |
Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice |
title_fullStr |
Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice |
title_full_unstemmed |
Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice |
title_sort |
pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice |
publisher |
Elsevier |
series |
Neurobiology of Disease |
issn |
1095-953X |
publishDate |
2012-01-01 |
description |
Pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptors (PAC1, VPAC) are present in sensory neurons and vascular smooth muscle. PACAP infusion was found to trigger migraine-like headache in humans and we showed its central pro-nociceptive function in several mouse pain models. Nitroglycerol (NTG)-induced pathophysiological changes were investigated in this study in PACAP gene-deleted (PACAP−/−) and wildtype (PACAP+/+) mice. Chemical activation of the trigeminovascular system was induced by 10 mg/kg i.p. NTG. Light-aversive behavior was determined in a light–dark box, meningeal microcirculation by laser Doppler blood perfusion scanning and the early neuronal activation marker c-Fos with immunohistochemistry. NTG-induced photophobia both in the early (0–30 min) and late phases (90–120 min) due to direct vasodilation and trigeminal sensitization, respectively, was significantly reduced in PACAP−/− mice. Meningeal blood flow increased by 30–35% during 4 h in PACAP+/+ mice, but only a 5–10% elevation occurred from the second hour in PACAP−/− ones. The number of c-Fos expressing cells referring to neuronal activation in the trigeminal ganglia and nucleus caudalis significantly increased 4 h after NTG in PACAP+/+, but not in PACAP−/− animals. Similar PAC1 receptor immunostaining was detected in both groups, which did not change 4 h after NTG treatment. PACAP-38 (300 μg/kg, i.p.) produced photophobia similarly to NTG and 30% meningeal vasodilatation for 30 min in PACAP+/+, but not in PACAP−/− mice. It significantly increased neural activation 4 h later in the trigeminal ganglia of both groups, but in the nucleus caudalis of only the PACAP+/+ mice.We provide the first experimental results that PACAP is a pivotal mediator of trigeminovascular activation/sensitization and meningeal vasodilation related to migraine. |
topic |
Light-aversive behavior Light–dark box Laser Doppler blood perfusion scanning Meningeal microcirculation c-Fos immunohistochemistry PAC1 receptor immunohistochemistry |
url |
http://www.sciencedirect.com/science/article/pii/S0969996111003421 |
work_keys_str_mv |
AT adriennmarkovics pituitaryadenylatecyclaseactivatingpolypeptideplaysakeyroleinnitroglycerolinducedtrigeminovascularactivationinmice AT viktoriakormos pituitaryadenylatecyclaseactivatingpolypeptideplaysakeyroleinnitroglycerolinducedtrigeminovascularactivationinmice AT balazsgaszner pituitaryadenylatecyclaseactivatingpolypeptideplaysakeyroleinnitroglycerolinducedtrigeminovascularactivationinmice AT arvinlashgarara pituitaryadenylatecyclaseactivatingpolypeptideplaysakeyroleinnitroglycerolinducedtrigeminovascularactivationinmice AT evaszoke pituitaryadenylatecyclaseactivatingpolypeptideplaysakeyroleinnitroglycerolinducedtrigeminovascularactivationinmice AT katalinsandor pituitaryadenylatecyclaseactivatingpolypeptideplaysakeyroleinnitroglycerolinducedtrigeminovascularactivationinmice AT krisztinaszabadfi pituitaryadenylatecyclaseactivatingpolypeptideplaysakeyroleinnitroglycerolinducedtrigeminovascularactivationinmice AT bernadetttuka pituitaryadenylatecyclaseactivatingpolypeptideplaysakeyroleinnitroglycerolinducedtrigeminovascularactivationinmice AT janostajti pituitaryadenylatecyclaseactivatingpolypeptideplaysakeyroleinnitroglycerolinducedtrigeminovascularactivationinmice AT janosszolcsanyi pituitaryadenylatecyclaseactivatingpolypeptideplaysakeyroleinnitroglycerolinducedtrigeminovascularactivationinmice AT erikapinter pituitaryadenylatecyclaseactivatingpolypeptideplaysakeyroleinnitroglycerolinducedtrigeminovascularactivationinmice AT hitoshihashimoto pituitaryadenylatecyclaseactivatingpolypeptideplaysakeyroleinnitroglycerolinducedtrigeminovascularactivationinmice AT jozsefkun pituitaryadenylatecyclaseactivatingpolypeptideplaysakeyroleinnitroglycerolinducedtrigeminovascularactivationinmice AT dorareglodi pituitaryadenylatecyclaseactivatingpolypeptideplaysakeyroleinnitroglycerolinducedtrigeminovascularactivationinmice AT zsuzsannahelyes pituitaryadenylatecyclaseactivatingpolypeptideplaysakeyroleinnitroglycerolinducedtrigeminovascularactivationinmice |
_version_ |
1724208611361554432 |
spelling |
doaj-af168d60755641929d761c3edfb1b7ff2021-03-22T12:37:42ZengElsevierNeurobiology of Disease1095-953X2012-01-01451633644Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in miceAdrienn Markovics0Viktoria Kormos1Balazs Gaszner2Arvin Lashgarara3Eva Szoke4Katalin Sandor5Krisztina Szabadfi6Bernadett Tuka7Janos Tajti8Janos Szolcsanyi9Erika Pinter10Hitoshi Hashimoto11Jozsef Kun12Dora Reglodi13Zsuzsanna Helyes14Department of Pharmacology and Pharmacotherapy, University of Pecs, Faculty of Medicine, H-7624, Pecs, Szigeti u. 12., HungaryDepartment of Pharmacology and Pharmacotherapy, University of Pecs, Faculty of Medicine, H-7624, Pecs, Szigeti u. 12., Hungary; Department of Anatomy, PTE-MTA Lendulet PACAP Research Group, University of Pecs, Faculty of Medicine, H-7624, Pecs, Szigeti u. 12., HungaryDepartment of Anatomy, PTE-MTA Lendulet PACAP Research Group, University of Pecs, Faculty of Medicine, H-7624, Pecs, Szigeti u. 12., HungaryDepartment of Pharmacology and Pharmacotherapy, University of Pecs, Faculty of Medicine, H-7624, Pecs, Szigeti u. 12., HungaryDepartment of Pharmacology and Pharmacotherapy, University of Pecs, Faculty of Medicine, H-7624, Pecs, Szigeti u. 12., HungaryDepartment of Pharmacology and Pharmacotherapy, University of Pecs, Faculty of Medicine, H-7624, Pecs, Szigeti u. 12., HungaryDepartment of Experimental Zoology and Neurobiology, University of Pecs, H-7624 Pecs, Faculty of Natural Sciences, Ifjusag u. 6., HungaryNeurology Department, University of Szeged, Faculty of Medicine, H-6725, Szeged, Semmelweis u. 6., HungaryNeurology Department, University of Szeged, Faculty of Medicine, H-6725, Szeged, Semmelweis u. 6., HungaryDepartment of Pharmacology and Pharmacotherapy, University of Pecs, Faculty of Medicine, H-7624, Pecs, Szigeti u. 12., Hungary; PharmInVivo Ltd., H-7629, Pecs, Szondi Gy. u. 10., HungaryDepartment of Pharmacology and Pharmacotherapy, University of Pecs, Faculty of Medicine, H-7624, Pecs, Szigeti u. 12., Hungary; PharmInVivo Ltd., H-7629, Pecs, Szondi Gy. u. 10., HungaryLaboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan; Center for Child Mental Development, United Graduate School of Child Development, Osaka University, Kanazawa University and Hamamatsu University School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan; Department of Molecular Pharmaceutical Science, Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, JapanDepartment of Pharmacology and Pharmacotherapy, University of Pecs, Faculty of Medicine, H-7624, Pecs, Szigeti u. 12., HungaryDepartment of Anatomy, PTE-MTA Lendulet PACAP Research Group, University of Pecs, Faculty of Medicine, H-7624, Pecs, Szigeti u. 12., HungaryDepartment of Pharmacology and Pharmacotherapy, University of Pecs, Faculty of Medicine, H-7624, Pecs, Szigeti u. 12., Hungary; PharmInVivo Ltd., H-7629, Pecs, Szondi Gy. u. 10., Hungary; Corresponding author at: Department of Pharmacology and Pharmacotherapy, University of Pécs, Pécs-7624, Szigeti u. 12., Hungary. Fax: +36 72 536218.Pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptors (PAC1, VPAC) are present in sensory neurons and vascular smooth muscle. PACAP infusion was found to trigger migraine-like headache in humans and we showed its central pro-nociceptive function in several mouse pain models. Nitroglycerol (NTG)-induced pathophysiological changes were investigated in this study in PACAP gene-deleted (PACAP−/−) and wildtype (PACAP+/+) mice. Chemical activation of the trigeminovascular system was induced by 10 mg/kg i.p. NTG. Light-aversive behavior was determined in a light–dark box, meningeal microcirculation by laser Doppler blood perfusion scanning and the early neuronal activation marker c-Fos with immunohistochemistry. NTG-induced photophobia both in the early (0–30 min) and late phases (90–120 min) due to direct vasodilation and trigeminal sensitization, respectively, was significantly reduced in PACAP−/− mice. Meningeal blood flow increased by 30–35% during 4 h in PACAP+/+ mice, but only a 5–10% elevation occurred from the second hour in PACAP−/− ones. The number of c-Fos expressing cells referring to neuronal activation in the trigeminal ganglia and nucleus caudalis significantly increased 4 h after NTG in PACAP+/+, but not in PACAP−/− animals. Similar PAC1 receptor immunostaining was detected in both groups, which did not change 4 h after NTG treatment. PACAP-38 (300 μg/kg, i.p.) produced photophobia similarly to NTG and 30% meningeal vasodilatation for 30 min in PACAP+/+, but not in PACAP−/− mice. It significantly increased neural activation 4 h later in the trigeminal ganglia of both groups, but in the nucleus caudalis of only the PACAP+/+ mice.We provide the first experimental results that PACAP is a pivotal mediator of trigeminovascular activation/sensitization and meningeal vasodilation related to migraine.http://www.sciencedirect.com/science/article/pii/S0969996111003421Light-aversive behaviorLight–dark boxLaser Doppler blood perfusion scanningMeningeal microcirculationc-Fos immunohistochemistryPAC1 receptor immunohistochemistry |